Keyphrases
2,3,5-triphenyltetrazolium Chloride
25%
A1 Receptor
25%
Cerebral Cortex
12%
Continuous Administration
12%
Continuous Treatment
12%
Cortical Infarction
12%
Focal Cerebral Ischemia
12%
Focal Ischemia
100%
Halothane
12%
Infarction Size
12%
Infarction Volume
37%
Ipsilateral Hemisphere
37%
Ischemia
25%
Ischemic Injury
12%
IV Administration
12%
IV Infusion
12%
Ligand-receptor Binding
25%
Neuroprotection
100%
Normothermia
12%
Normoxia
12%
Occlusion
12%
Phenyl
100%
Piperidine
100%
Prolonged Treatment
12%
Rat Model
12%
Reperfusion
12%
Therapeutic Efficacy
12%
Transient Focal Ischemia
12%
Transient Middle Cerebral Artery Occlusion (tMCAO)
12%
Treatment Duration
100%
Treatment Group
12%
Wistar Rats
12%
Neuroscience
Brain Ischemia
12%
Cerebral Cortex
12%
Cerebrovascular Accident
12%
Halothane
12%
Ischemia
100%
Middle Cerebral Artery
12%
Neuroprotection
100%
Piperidine
100%
Receptor
25%
Scanning Electron Microscopy
12%
Staining Technique
12%